Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2024-09-03 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
TOTAL VOTING RIGHTS
Foreign Filer Report
2024-09-03 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is identified by the 'RNS Number' header and explicitly mentions 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider'. The content details the total number of voting rights and issued share capital as of a specific date (31 August 2024), referencing the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. This type of mandatory disclosure regarding voting rights and capital structure is a specific regulatory announcement. While it relates to capital, it is not a financing activity (CAP) or a share repurchase (POS), but rather a mandatory disclosure of the current voting denominator. This fits best under the general 'Regulatory Filings' (RNS) category, as it is a standard, periodic regulatory update that doesn't fit the more specific categories like DVA (which is for *results* of a vote) or SHA (which is for *changes* in capital structure, not just reporting the current total). Given the context of RNS and mandatory disclosure, RNS is the most appropriate classification.
2024-09-02 English
IMFINZI APPROVED IN US FOR RESECTABLE LUNG CANCER
Foreign Filer Report
2024-08-16 English
Imfinzi approved in US for resectable lung cancer
Regulatory Filings Classification · 1% confidence The document starts with 'RNS Number : 6767A' and is dated '16 August 2024'. It announces a specific corporate event: the FDA approval of Imfinzi for NSCLC treatment. This format (RNS Number, date, brief announcement of a material event) is characteristic of a Regulatory News Service (RNS) announcement, which serves as a general regulatory filing for immediate market disclosure, fitting the definition of 'Regulatory Filings' (RNS) or potentially an 'Earnings Release' (ER) if it were financial results. Since this is a clinical/regulatory milestone announcement rather than financial results, and it is explicitly marked with an RNS number, the most appropriate classification is RNS, which is the designated fallback for general regulatory announcements not covered by more specific codes like 10-K or ER.
2024-08-16 English
TOTAL VOTING RIGHTS
Foreign Filer Report
2024-08-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official notification released via RNS (Regulatory News Service) on August 1, 2024. The content explicitly states it is a notification made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1, detailing the total number of issued shares with voting rights (1,550,277,001) as of July 31, 2024. This type of filing, which reports changes in the total number of voting rights, is a standard regulatory disclosure. While it relates to capital structure, it is not a financing announcement (CAP) or a share issue (SHA). It is a specific regulatory update concerning voting rights denominator. Since there is no specific code for 'Voting Rights Denominator Update', and it is a mandatory regulatory disclosure that doesn't fit other specific categories like DIRS (Director's Dealing) or MRQ (Major Shareholding Notification), the most appropriate general regulatory category is RNS (Regulatory Filings), as it is distributed via the RNS system and serves as a general regulatory announcement.
2024-08-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.